Breast Cancer Index^® may improve clarity for you and your oncology team as you consider the duration of your anti-estrogen therapy — in fact, it’s the only validated, commercially available test that can tell you whether you’re likely to benefit from treatment after 5 years.

Knowing your risk of recurrence after 5 years of therapy and whether or not additional anti-estrogen therapy is likely to benefit you gives you the information to make joint decisions with your oncology team. Tolerating side effects is not always necessary, understanding your benefit is.

Not Another Minute Not Knowing If Treatment Is Benefiting You

You can’t take the fear out of cancer.
But you can reduce the
uncertainty around treating it.

Use this conversation guide to talk to your doctor about managing side effects and where BCI fits in your plan.

Download Conversation Guide

Side Effects: An Expected Part of Treatment

If you experience uncomfortable and frustrating side effects as a result of taking anti-estrogen therapy routinely, you are not alone. And while many of these may have a negative impact on your everyday life, some have the potential to pose an even greater risk to your health.^7-11

Possible side effects for aromatase inhibitors:^7-10

Hot flashes
Joint pain and stiffness
Vaginal dryness
Hair thinning
High cholesterol
High blood pressure
Osteoporosis
Bone fractures

Possible side effects for tamoxifen:¹¹

Mood swings
Hot flashes
Vaginal dryness
Weight gain
Early-onset menopause
Cataracts
Blood clots
Endometrial cancer
Stroke

Breast Cancer Index Is Changing
The Game.

While some women may benefit from continuing anti-estrogen therapy beyond 5 years, many women do not — it’s important to talk with your doctor about whether the potential benefit outweighs the side effects and risks that may come with five more years of treatment.

Whether or not you are likely to benefit, Breast Cancer Index gives you and your doctor information you need to make the right treatment decision for you.

The Test Will Give You Information To Help You Answer These Questions:

Am I likely to benefit from anti-estrogen therapy beyond 5 years?
What is my risk of late-distant recurrence after 5 years?

This test can be an important tool in helping you and your oncology team determine whether an additional five years of anti-estrogen therapy may be beneficial for you.

The test is performed only by Biotheranostics, Inc.

The Breast Cancer Timeline

If you’ve been diagnosed with breast cancer, it may be hard to think beyond the minute you’re in. But the results of your Breast Cancer Index test can help give you and your oncology team more certainty as you develop your treatment plan.

Diagnosis is the first step

The first point on the timeline for cancer treatment is what doctors refer to as “Time Zero.” For patients, this can be a world-shattering time full of chaos and information overload.

Anti-Estrogen Therapy Is The Standard Course Of Treatment

While anti-estrogen, or “endocrine,“ therapy is a standard course of treatment for hormone receptor–positive (HR+) breast cancer, the duration of treatment is an important decision for you and your oncology team to discuss.¹²

Nearly 95% of Women Do Not Benefit From Treatment After 5 Years^1-6

While most women with early-stage HR+ breast cancer are prescribed anti-estrogen therapy, the duration of treatment may vary from patient to patient — at least 5 years of anti-estrogen therapy is usually recommended to help prevent a recurrence of your cancer. ¹²

Breast Cancer Index can help you and your doctor determine whether a longer course of treatment is likely to benefit you.

Talk to your doctor about Breast Cancer Index to understand when the test may be right for you.

Download The Conversation Guide

Know If Additional Treatment Is Right For You

For some women, extending anti-estrogen therapy through year 10 may reduce the risk of recurrence.

Breast Cancer Index can help you and your doctor decide what is right for you.